Advertisement

Topics

Oxford Gene Technology Company Profile

23:22 EDT 20th October 2017 | BioPortfolio

DNA microassays consisting of in situ synthesises oligonucleotide probes.

Location

BioBuisness Centre
Oxford
Oxfordshire
OX4 4SS
United Kingdom

Contact

Phone: 44 1865 405118
Fax: 44 1865 405120
Email: andy.millar@ogt.co.uk


News Articles [1627 Associated News Articles listed on BioPortfolio]

Oxford Gene Technology: Mike Evans. Providers of innovative genetics research and biomarker solutions to advance molecular medicine

Mike Evans, CEO of Oxford Gene Technology talks to Fintan Walton about OGT's new diagnostic techiques and innovative research into Lupus, Prostate and Colorectal cancers.

Oxford Spinout goes for $75M IPO on Nasdaq to Fund Gene Therapy Programs

Nightstar has gone public on the American market with the aim of raising $75M for its gene-based retinal disease cures. Spun out from Oxford in 2013, Nightstar is developing and commercializing one-s...

Profit finally in sight for gene therapy specialist Oxford Bio

LONDON (Reuters) - After 20 years of losses, gene therapy specialist Oxford BioMedica is at last close to achieving its first profit thanks to the success of Novartis with a pioneering cancer treatmen...

Oxford BioMedica enters gene and cell therapy manufacturing project

Gene and cell therapy group, Oxford BioMedica (OXB), has agreed to enter into a collaboration project as lead partner that will focus on gene and cell therapy manufacturing and will be co-funded by th...

Sysmex Corporation to Acquire Oxford Gene Technology

Sysmex Corporation (Kobe, Japan), an in vitro diagnostic company, has entered into an agreement to acquire molecular genetics company, Oxford...

Oxford BioMedica announces collaboration for gene and cell therapy manufacturing

A new consortium, led by Oxford BioMedica, will take part in a two-year, £2m project focused on gene and cell therapy manufacturing.

Oxford BioMedica: Vector Value: An Interview with Nick Woolf, SVP Corporate Strategy

Fintan Walton talks to Nick Woolf, Senior Vice President, Corporate Strategy, Oxford BioMedica, about the company’s ongoing success as it moves toward its ultimate goal of becoming a fully integrate...

Isis Innovation: How the Oxford Sciences Innovation fund is promoting investment in the Oxfordshire region

Adam Stoten, head of Technology Transfer at Isis Innovation (the technology transfer arm of the University of Oxford) discusses the recent successes of Oxford Sciences Innovation (OSI), a fund compris...

PubMed Articles [3279 Associated PubMed Articles listed on BioPortfolio]

Meta-analytic framework for liquid association.

Although coexpression analysis via pair-wise expression correlation is popularly used to elucidate gene-gene interactions at the whole-genome scale, many complicated multi-gene regulations require mor...

Real-time demultiplexing Nanopore barcoded sequencing data with npBarcode.

The recent introduction of a barcoding protocol for Oxford Nanopore sequencing has increased the versatility of the technology. Several bioinformatics tools have been developed to demultiplex barcoded...

Molecular tools for gene manipulation in filamentous fungi.

Functional genomics of filamentous fungi has gradually uncovered gene information for constructing 'cell factories' and controlling pathogens. Available gene manipulation methods of filamentous fungi ...

Ethical issues of CRISPR technology and gene editing through the lens of solidarity.

The avalanche of commentaries on CRISPR-Cas9 technology, a bacterial immune system modified to recognize any short DNA sequence, cut it out, and insert a new one, has rekindled hopes for gene therapy ...

CESAR 2.0 substantially improves speed and accuracy of comparative gene annotation.

Homology-based gene prediction is a powerful concept to annotate newly sequenced genomes. We have previously demonstrated that whole genome alignments can be utilized for accurate comparative coding g...

Clinical Trials [2713 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

A Clinical Investigation of the Oxford® Partial Knee System

The purpose of this prospective data collection is to document the performance and clinical outcomes of the Oxford® Partial Knee System.

Companies [1041 Associated Companies listed on BioPortfolio]

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

Oxford BioMedica

Oxford BioMedica advanced gene therapy techniques.

BioMedica Inc.

Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development of novel gene-based therapeutics with a focus on the areas of oncology and neurotherapy. The Company was esta...

Oxford Gene Technology

DNA microassays consisting of in situ synthesises oligonucleotide probes.

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

More Information about "Oxford Gene Technology" on BioPortfolio

We have published hundreds of Oxford Gene Technology news stories on BioPortfolio along with dozens of Oxford Gene Technology Clinical Trials and PubMed Articles about Oxford Gene Technology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Gene Technology Companies in our database. You can also find out about relevant Oxford Gene Technology Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...


Corporate Database Quicklinks



Searches Linking to this Company Record